Evoq Therapeutics, Inc.
Ann Arbor, MI
- UEI
- KC7MPKPPJDE7
- CAGE
- 7RBJ5
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1600 Huron Pkwy, Ann Arbor, MI 48109, USA
- Website
- evoqtherapeutics.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nanodiscs for immune modulation in celiac disease - project summary/abstract celiac disease (CED) affects… | National Institute of Allergy and Infectious Diseases | $2,050,000 | |
| New approach for immune modulation against T1D - project summary/abstract type 1 diabetes (T1D) is an autoimmune disease… | National Institute of Diabetes and Digestive and Kidney Diseases | $2,280,109 | |
| Novel immunotherapy against MOG antibody disease - project summary/abstract myelin oligodendrocyte glycoprotein (MOG)… | National Center for Advancing Translational Sciences | $1,988,943 | |
| Novel immunotherapy against MOG antibody disease - project summary/abstract myelin oligodendrocyte glycoprotein (MOG)… | National Institute of Allergy and Infectious Diseases | $575,466 |
About Evoq Therapeutics, Inc.
Evoq Therapeutics, Inc. is a biotechnology company located in Ann Arbor, Michigan, focused on developing innovative nanotechnology-based therapeutic platforms for addressing autoimmune and inflammatory diseases. Registered in SAM.gov since October 2016, the company operates as a for-profit corporate entity specializing in advanced drug delivery technologies, specifically synthetic high-density lipoprotein nanodiscs designed for targeted immune modulation and therapeutic intervention.
Evoq Therapeutics has received multiple federal grant awards from prestigious national research institutes, including the National Institute of Allergy and Infectious Diseases, the National Center for Advancing Translational Sciences, and the National Institute of Diabetes and Digestive and Kidney Diseases. Their research grants focus on developing nanodisk-based immunotherapies for complex autoimmune conditions such as Type 1 Diabetes, Celiac Disease, and Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease. The company's research strategy involves formulating synthetic nanodiscs capable of delivering peptide antigens directly to lymph nodes, with the goal of promoting immune tolerance and potentially revolutionizing treatment approaches for challenging autoimmune disorders. Their scientific approach emphasizes precise antigen delivery, regulatory T cell modulation, and targeted immune system intervention, demonstrating a sophisticated and innovative approach to treating previously difficult-to-manage medical conditions through advanced nanotechnology platforms.
Quick answers
What is Evoq Therapeutics, Inc.'s UEI?
Evoq Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is KC7MPKPPJDE7.
What is Evoq Therapeutics, Inc.'s CAGE code?
Evoq Therapeutics, Inc.'s CAGE code is 7RBJ5.
Where is Evoq Therapeutics, Inc. located?
Evoq Therapeutics, Inc.'s physical address in SAM.gov is 1600 Huron Pkwy, Ann Arbor, MI 48109, USA.
Is Evoq Therapeutics, Inc. registered in SAM.gov?
Yes. Evoq Therapeutics, Inc.'s SAM.gov registration is active through September 17, 2027.
What is Evoq Therapeutics, Inc.'s most recent federal award?
Evoq Therapeutics, Inc.'s most recent federal grant award is Nanodiscs for immune modulation in celiac disease - project summary/abstract celiac disease (CED) affects… (R44AI192013), from National Institute of Allergy and Infectious Diseases, on September 19, 2025.
On GovTribe
See Evoq Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors